Efficacy of Virtual Reality Exercises in STroke Rehabilitation: A Multicentre Study (EVREST Multicentre)
|ClinicalTrials.gov Identifier: NCT01406912|
Recruitment Status : Completed
First Posted : August 1, 2011
Last Update Posted : November 13, 2015
A multicentre, randomized, two parallel group study comparing virtual reality using Wii gaming technology versus Recreational activities in patients receiving conventional rehabilitation after an ischemic stroke.
Primary Hypothesis: Virtual reality using the Wii gaming system is more efficacious in improving motor function than recreational therapy among patients receiving conventional rehabilitation following a recent ischemic stroke.
|Condition or disease||Intervention/treatment||Phase|
|Ischemic Stroke||Other: Recreational Activity Other: Wii Gaming System Arm||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||141 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Efficacy of Virtual Reality Exercises Using Wii Gaming Technology in STroke Rehabilitation: A Multicentre Randomized Clinical Trial (EVREST Multicentre)|
|Study Start Date :||July 2011|
|Actual Primary Completion Date :||October 2015|
|Actual Study Completion Date :||October 2015|
Active Comparator: Recreational Activity Arm
recreational activity includes playing cards, ominoes, jenga or a ball game.
Other: Recreational Activity
Recreational activities (playing cards, arts and crafts, dominoes, jenga or a ball game) and conventional rehabilitation.
Experimental: Wii Gaming System Arm
Use of Wii gaming technology (e.g. commercially available games)
Other: Wii Gaming System Arm
Virtual reality Wii games (tennis and bowling from Wii® Sports, and bean bag, bocce ball, ping cup, darts or shuffleboard from Wii® Game Party 3) and conventional rehabilitation.
Other Name: Virtual Reality Wii games
- Difference in motor performance between groups measured using the Wolf Motor function Test. [ Time Frame: 1 (±3) days after the end of the intervention ]Efficacy in motor function improvement at the end of the intervention will be measured by the abbreviated Wolf Motor Function Test. The Wolf MFT is a time-based method to evaluate upper extremity performance while providing insight into total limb movements. It consists of 15 timed measures and 2 force-based measures which progress in complexity. Difference in Wolf MFT is one of the most commonly used outcome measures in stroke rehabilitation trials.
- Improvement in motor function, performing activities of daily living, and quality of life, as well as sustainability of motor improvement [ Time Frame: End of intervention and 4 weeks post-intervention ]Secondary efficacy outcome measures include Box & Block Test, quality of life as measured by the Stroke Impact Scale, and Barthel Index at the end of the interventions. In addition, sustainability of motor improvement will be assessed through the Wolf Motor Function Test and Box & Block Test conducted at 4 weeks post-intervention, which is approximately 3 months from stroke onset.
- Proportion of patients experiencing intervention-related adverse events or any serious adverse events during the study period [ Time Frame: Subjects will be followed for the duration of their participation in the study, an expected time frame of 6 weeks ]Secondary safety outcome will be measured as the proportion of patients experiencing intervention-related adverse events (e.g. pain, dizziness), or any serious adverse event (death, life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, or results in persistent or significant disability/incapacity) during the study period. We will also measure patients' perceived exertion after treatment by using the Borg Perceived Exertion scale (excessive fatigue defined as any score > 13 points)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01406912
|Buenos Aires, Argentina|
|Lucy Montoro Network|
|Sao Paulo, Brazil|
|University of Calgary|
|Calgary, Alberta, Canada, T2N 0P8|
|Riverview Health Centre|
|Winnipeg, Manitoba, Canada, R3L 2P4|
|Canada, Newfoundland and Labrador|
|LA Miller Centre|
|St John's, Newfoundland and Labrador, Canada|
|Hamilton Health Sciences|
|Hamilton, Ontario, Canada, L8L 2X2|
|Parkwood Hospital, St. Joseph's Health Care London|
|London, Ontario, Canada, N6C 5J1|
|Trillium Health Partners|
|Mississauga, Ontario, Canada, L5B 1B8|
|Scarborough, Ontario, Canada, M1L 1W1|
|Toronto Rehabilitation Institute|
|Toronto, Ontario, Canada, M5G 2A2|
|CSSS Cavendish Richardson Hospital|
|Montreal, Quebec, Canada|
|Clinica San Felipe|
|Principal Investigator:||Gustavo Saposnik, MD||St. Michael's Hospital, Toronto|
|Principal Investigator:||Mark Bayley, MD||Toronto Rehabilitation Institute|